ThePeptideGuide.uk LogoNavigation

Educational purposes only. Not medical advice. Consult healthcare professionals before use.

Healing & Recovery
Phase 2

Ac-SDKP

Ac-SDKP

Also known as: Thymosin Beta-4 Fragment Ac-SDKP, Goralatide, Seraspenide

Overview

Key Facts

Primary Goal: A tetrapeptide naturally released from Thymosin Beta-4 by prolyl oligopeptidase

A tetrapeptide naturally released from Thymosin Beta-4 by prolyl oligopeptidase. Acts as a potent endogenous antifibrotic agent and is normally present in human plasma and urine. Hydrolyzed by ACE. Half-Life ~5 minutes (rapidly cleaved by ACE) Typical Dose 100–400 mcg Frequency 1x daily Cycle Length 4-8 weeks

Dosing Information

Half-Life

~5 minutes (rapidly cleaved by ACE)

Typical Dose

100–400 mcg

Frequency

1x daily

Cycle Length

4-8 weeks

Administration Routes:

subcutaneousintravenous

Storage & Reconstitution

Unreconstituted (Powder)

Temperature2–8°C (36–46°F) or -20°C (-4°F) for long-term
DurationUp to 3 months

Reconstituted (Mixed)

Temperature2–8°C (36–46°F)
Duration2-4 weeks

Research Summary

Phase 2

Studied extensively in animal models of cardiac, renal, and hepatic fibrosis with consistent antifibrotic results. Its role as the endogenous substrate of ACE partly explains the antifibrotic benefits of ACE inhibitors. Phase 1 human data exists from hematopoietic studies (Goralatide/Seraspenide).

Frequently Asked Questions

Common questions about Ac-SDKP

UK-Specific Information

Exclusive data points and guidance for UK residents using Ac-SDKP

UK Lab Testing

US Lab Testing

Recommended labs: Quest Diagnostics, LabCorp ($120-$200 for peptide safety panel)

Why this matters: UK-specific lab testing guidance not available on US competitor sites

Commonly Stacked With